BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 24467325)

  • 21. Synthesis, characterization and anti-inflammatory properties of karanjin (Pongamia pinnata seed) and its derivatives.
    Rekha MJ; Bettadaiah BK; Muthukumar SP; Govindaraju K
    Bioorg Chem; 2021 Jan; 106():104471. PubMed ID: 33257003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular pharmacological profile of a novel thiazolinone-based direct and selective 5-lipoxygenase inhibitor.
    Hofmann B; Rödl CB; Kahnt AS; Maier TJ; Michel AA; Hoffmann M; Rau O; Awwad K; Pellowska M; Wurglics M; Wacker M; Zivković A; Fleming I; Schubert-Zsilavecz M; Stark H; Schneider G; Steinhilber D
    Br J Pharmacol; 2012 Apr; 165(7):2304-13. PubMed ID: 21955369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological evaluation and molecular docking of new di-tert-butylphenol compound, LQFM-091, a new dual 5-LOX/COX inhibitor.
    Lino RC; da Silva DPB; Florentino IF; da Silva DM; Martins JLR; Batista DDC; Leite KCS; Villavicencio B; Vasconcelos GA; Silva ALP; de Ávila RI; Verli H; Valadares MC; Gil ES; Vaz BG; Lião LM; Menegatti R; Costa EA
    Eur J Pharm Sci; 2017 Aug; 106():231-243. PubMed ID: 28599988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis and pharmacobiological evaluation of novel acrylic acid derivatives acting as lipoxygenase and cyclooxygenase-1 inhibitors with antioxidant and anti-inflammatory activities.
    Pontiki E; Hadjipavlou-Litina D; Litinas K; Nicolotti O; Carotti A
    Eur J Med Chem; 2011 Jan; 46(1):191-200. PubMed ID: 21106277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and Biological Evaluation of N-Aryl-5-aryloxazol-2-amine Derivatives as 5-Lipoxygenase Inhibitors.
    Suh JH; Yum EK; Cho YS
    Chem Pharm Bull (Tokyo); 2015; 63(8):573-8. PubMed ID: 26040270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual inhibitors of thromboxane A2 synthase and 5-lipoxygenase with scavenging activity of active oxygen species. Synthesis of a novel series of (3-pyridylmethyl)benzoquinone derivatives.
    Ohkawa S; Terao S; Terashita Z; Shibouta Y; Nishikawa K
    J Med Chem; 1991 Jan; 34(1):267-76. PubMed ID: 1992126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pteridine-2,4-diamine derivatives as radical scavengers and inhibitors of lipoxygenase that can possess anti-inflammatory properties.
    Pontiki E; Hadjipavlou-Litina D; Patsilinakos A; Tran TM; Marson CM
    Future Med Chem; 2015; 7(14):1937-51. PubMed ID: 26423719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conjugation of 4-aminosalicylate with thiazolinones afforded non-cytotoxic potent in vitro and in vivo anti-inflammatory hybrids.
    Abdu-Allah HHM; Abdelmoez AAB; Tarazi H; El-Shorbagi AA; El-Awady R
    Bioorg Chem; 2020 Jan; 94():103378. PubMed ID: 31677858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aspirin analogues as dual cyclooxygenase-2/5-lipoxygenase inhibitors: synthesis, nitric oxide release, molecular modeling, and biological evaluation as anti-inflammatory agents.
    Kaur J; Bhardwaj A; Huang Z; Knaus EE
    ChemMedChem; 2012 Jan; 7(1):144-50. PubMed ID: 22095955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel series of benzoquinones with high potency against 5-lipoxygenase in human polymorphonuclear leukocytes.
    Filosa R; Peduto A; Schaible AM; Krauth V; Weinigel C; Barz D; Petronzi C; Bruno F; Roviezzo F; Spaziano G; D'Agostino B; De Rosa M; Werz O
    Eur J Med Chem; 2015 Apr; 94():132-9. PubMed ID: 25765759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and docking studies of 2,4,6-trihydroxy-3-geranylacetophenone analogs as potential lipoxygenase inhibitor.
    Ng CH; Rullah K; Aluwi MF; Abas F; Lam KW; Ismail IS; Narayanaswamy R; Jamaludin F; Shaari K
    Molecules; 2014 Aug; 19(8):11645-59. PubMed ID: 25100256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of selective 5-LOX and FLAP inhibitors as novel anti-inflammatory agents by ligand-based virtual screening.
    Cerchia C; Küfner L; Werz O; Lavecchia A
    Eur J Med Chem; 2024 Jan; 263():115932. PubMed ID: 37976708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis, in vivo anti-inflammatory, COX-1/COX-2 and 5-LOX inhibitory activities of new 2,3,4-trisubstituted thiophene derivatives.
    Qandeel NA; El-Damasy AK; Sharawy MH; Bayomi SM; El-Gohary NS
    Bioorg Chem; 2020 Sep; 102():103890. PubMed ID: 32801081
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacology of PF-4191834, a novel, selective non-redox 5-lipoxygenase inhibitor effective in inflammation and pain.
    Masferrer JL; Zweifel BS; Hardy M; Anderson GD; Dufield D; Cortes-Burgos L; Pufahl RA; Graneto M
    J Pharmacol Exp Ther; 2010 Jul; 334(1):294-301. PubMed ID: 20378715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design, synthesis and identification of novel substituted 2-amino thiazole analogues as potential anti-inflammatory agents targeting 5-lipoxygenase.
    Sinha S; Doble M; Manju SL
    Eur J Med Chem; 2018 Oct; 158():34-50. PubMed ID: 30199704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New hybrid molecules combining benzothiophene or benzofuran with rhodanine as dual COX-1/2 and 5-LOX inhibitors: Synthesis, biological evaluation and docking study.
    El-Miligy MMM; Hazzaa AA; El-Messmary H; Nassra RA; El-Hawash SAM
    Bioorg Chem; 2017 Jun; 72():102-115. PubMed ID: 28390993
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, anti-inflammatory, analgesic, 5-lipoxygenase (5-LOX) inhibition activities, and molecular docking study of 7-substituted coumarin derivatives.
    Srivastava P; Vyas VK; Variya B; Patel P; Qureshi G; Ghate M
    Bioorg Chem; 2016 Aug; 67():130-8. PubMed ID: 27376460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis and identification of novel coumaperine derivatives for inhibition of human 5-LOX: Antioxidant, pseudoperoxidase and docking studies.
    Muthuraman S; Sinha S; Vasavi CS; Waidha KM; Basu B; Munussami P; Balamurali MM; Doble M; Saravana Kumar R
    Bioorg Med Chem; 2019 Feb; 27(4):604-619. PubMed ID: 30638966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of spirostanol glycosides and furostanol glycosides from anemarrhenae rhizoma as dual targeted inhibitors of 5-lipoxygenase and Cyclooxygenase-2 by employing a combination of affinity ultrafiltration and HPLC/MS.
    Xie L; Lee DY; Shang Y; Cao X; Wang S; Liao J; Zhang T; Dai R
    Phytomedicine; 2020 Oct; 77():153284. PubMed ID: 32707371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel N-substituted indole Schiff bases as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase enzymes: Synthesis, biological activities in vitro and docking study.
    Lamie PF; Ali WAM; Bazgier V; Rárová L
    Eur J Med Chem; 2016 Nov; 123():803-813. PubMed ID: 27541263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.